Improving lipid nanoparticle formulations for targeted delivery of genome editors

Although there have been significant innovations in the lipid nanoparticle (LNP) field in recent times, researchers face complex challenges including stability and target specificity. David McCall, Senior Editor, BioInsights, speaks with Rohit Sharma, Assistant Project Scientist, Innovative Genomics Institute, University of California, Berkeley, about methods to overcome these lingering issues and realize the potential of LNPs to revolutionize therapeutic strategies, particularly in the burgeoning area of in vivo genome editor delivery.

Please enter your email to access content Read now